Skip to content

GoodRx

US · GDRX #3178 by market cap Listed 2020
2.92 -0.10 -3.31%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:50

Price chart

Pre-market 3.05 +0.99%
After-hours 2.88 -1.37%
3.802.562.922026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on GDRX?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -3.3% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 1.0% of float.
  • Analyst tilt is Sell.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall C

The radar needs all six factors. Available grades are shown below.

Valuation C-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 48.7x Better than 10%
Forward P/E 27.7x Better than 21%
Price / Sales 1.5x Better than 65%
P/E vs own 5-yr range 80th pctl Better than 26%
Growth C

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 1.3% Better than 32%
Free cash flow CAGR (3Y) 0.8% Better than 39%
Profitability B-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 92.8% Better than 97%
Operating margin 11.0% Better than 54%
Net margin 3.8% Better than 39%
Return on equity 4.5% Better than 36%
Return on invested capital 4.6% Better than 43%
Momentum B

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -15.4% Better than 39%
6-month return 10.2% Better than 72%
12-month return (ex latest month) 33.6% Better than 72%
Distance below 52-week high 24.9% Better than 51%
Financial Health B

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.6x Better than 68%
Debt to assets 38.7% Better than 28%
Interest coverage 2.3x Better than 39%
Free cash flow / net income 308.4% Better than 86%
Analyst View N/A

What the Street thinks: share of Buy ratings and upside to the average target.

Not enough data to grade this factor.

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -17.98%
1M -17.05%
3M -17.98%
6M +15.87%
YTD +7.75%
1Y +11.45%
3Y -49.31%
5Y -92.70%

Key statistics

Price & volume

Prev close
3.02
Open
2.98
Day range
2.91 - 3.09
Avg price
2.97
Volume
2.01M
Turnover
5.97M
Amplitude
5.96%
52-week range
1.77 - 3.89

Valuation

P/E
32.44
P/E (TTM)
48.67
P/B
1.54
EPS
0.09
Net profit
30.70M
Net assets
647.49M

Share structure

Market cap
996.14M
Float cap
272.92M
Shares out
341.15M
Float shares
93.47M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2020-09-23
52-week range 54% of range
1.77 3.89

24.9% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-1.81M net over the window

Short interest

Shares short
3.57M
As of
2026-10-30

Frequently asked questions

What is the current stock price of GoodRx (GDRX)?

GoodRx last traded at 2.92. This page shows a periodic quote snapshot. Check the displayed quote time.

What is GoodRx's market cap?

About 996.14M.

What is the P/E ratio of GoodRx?

The trailing twelve-month P/E is 48.67. The Valuation tab shows it against the stock's own five-year range.

Does GoodRx pay a dividend?

GoodRx does not currently pay a regular dividend.

Is GoodRx a buy according to analysts?

The consensus of 1 analysts is a Sell rating, with an average 12-month price target of 2.65, which implies 9.2% downside from the current price. This is not investment advice.

What is GoodRx's StockVane Quant Rating?

The StockVane Momentum strategy currently rates GoodRx a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:50:20 · For reference only, not investment advice and not tailored to your situation.

GoodRx discussion 0 comments

Add a comment